Hepatocellular carcinoma (HCC) is one of the most prevalent cancers globally. In contrast to
the declining death rates observed for all other common cancers such as breast, lung, and …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, in
part because of inadequate early detection strategies. Current recommendations for …

In this study, we performed a comprehensively analysis of gene expression and DNA
methylation data to establish diagnostic, prognostic, and recurrence models for …

Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

The most common primary liver cancer is hepatocellular carcinoma (HCC), and its mortality
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and
the cancer with the fastest increase in mortality in the United States, with more than 39,000 …

Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related mortality worldwide.
Early detection of HCC enables patients to avail curative therapies that can improve patient …

Despite significant advances in the understanding of cancer biology, cancer is still a leading
cause of death worldwide. Expression of the tumor microenvironment component …

Simple Summary Hepatocellular carcinoma and cholangiocarcinoma continue to remain a
serious threat. In this review, we describe the most common biomarkers and genetic markers …

Cirrhosis is a primary cause of liver-related mortality and morbidity. The basic process
driving chronic liver disease to cirrhosis is accelerated fibrogenesis. Although the …